Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics ; volume:3 ; number:1 ; day:21 ; month:4 ; year:2015 ; pages:1-7 ; date:12.2015
Journal for ImmunoTherapy of Cancer ; 3, Heft 1 (21.4.2015), 1-7, 12.2015
- Creator
-
Sayour, Elias J.
- Contributor
-
Sanchez-Perez, Luis
Flores, Catherine
Mitchell, Duane A.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-015-0058-0
- URN
-
urn:nbn:de:1111-201610305323
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sayour, Elias J.
- Sanchez-Perez, Luis
- Flores, Catherine
- Mitchell, Duane A.
- SpringerLink (Online service)
Other Objects (12)
Immunotherapy and vaccines
Targeted transduction of T cell subsets for immunotherapy of cancer and infectious disease
Immunotherapy and vaccination against infectious diseases
Combination therapies utilizing neoepitope-targeted vaccines
Developing vaccines against epidemic-prone emerging infectious diseases
Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases
BCMA-targeted immunotherapy for multiple myeloma
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Research progress on dendritic cell vaccines in cancer immunotherapy
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
Live vaccines—a short‐cut to cancer viro‐immunotherapy
Immunotherapy and vaccines
Targeted transduction of T cell subsets for immunotherapy of cancer and infectious disease
Immunotherapy and vaccination against infectious diseases
Combination therapies utilizing neoepitope-targeted vaccines
Developing vaccines against epidemic-prone emerging infectious diseases
Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases
BCMA-targeted immunotherapy for multiple myeloma
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Research progress on dendritic cell vaccines in cancer immunotherapy
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
Live vaccines—a short‐cut to cancer viro‐immunotherapy
Immunotherapy and vaccines
Targeted transduction of T cell subsets for immunotherapy of cancer and infectious disease
Immunotherapy and vaccination against infectious diseases
Combination therapies utilizing neoepitope-targeted vaccines
Developing vaccines against epidemic-prone emerging infectious diseases
Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases
BCMA-targeted immunotherapy for multiple myeloma
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Research progress on dendritic cell vaccines in cancer immunotherapy
Telomerase-based vaccines: a promising frontier in cancer immunotherapy